ArticleThe oncologist2025

Investigating incidence of RAS/RAF and PIK3CA alterations in HER2-amplified colorectal cancer: a comprehensive analysis.

Svea Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.